LAB
Standard BioTools Inc. · Healthcare
Casdin Partners Master Fund, L.P. bought $443K of Standard BioTools Inc.
Director and 10% owner
Bought$443,033
$1.24Price
358,220Shares
What LAB did for a copier
- $1,000 copied at Mon, Aug 18 open, $1.28
- $1,016
- S&P 500, same days
- +3.9%
Measured over 30 trading days, to the Sep 30 close.
Casdin Partners Master Fund, L.P.'s record
18 other buys with 3 months of prices since 2020: on average −9.5% against the S&P 500, and 7 of 18 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Aug 13. Filed Fri, Aug 15, 5:18 PM ET, after the close. Returns use the Aug 18 open and the Sep 30 close. Not investment advice.